You are here

  • Home
  • Archive
  • Volume 15, Issue 5
  • B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus

Article info

Article menu
Download PDFPDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus

Authors

  1. Correspondence to Professor Somesh Gupta; someshgupta{at}aiims.edu
View Full Text

Citation

Mehta N, Baskaran N, Arava S, et al
B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus
BMJ Case Reports CP 2022;15:e248476.

Publication history

  • Accepted May 11, 2022
  • First published May 27, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.